COMBINED USE OF EGF PATHWAY INHIBITORS AND DIFFERENTIATION PROMOTING COMPOUNDS

摘要

The present invention is a pharmaceutical composition and method for its use in the treatment of chronic inflammatory skin diseases such as psoriasis. The pharmaceutical composition combines an inhibitor of the EGF receptor signaling pathway with an agent that promotes cell differentiation. This pharmaceutical composition may be administered orally or topically, and results in superior treatment of chronic inflammatory skin diseases than methods presently in use.